MyFinsight
Home
Blog
About
Biofrontera Inc. (BFRI)
Biofrontera Inc. (BFRI)
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Free Cash flow
-$1,658K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Accounts payable
Other assets, related party
Stock-based compensation
Others
Negative Cash Flow Breakdown
Accounts receivable
Accrued expenses and other liabi...
Accounts payable, related partie...
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Net loss
-604
-4,752
5,640
-6,649
Loss on debt extinguishment
-
-
0
0
Depreciation
-
-
-
17
Depreciation and amortization
65
55
138
-
Loss on settlement of lease liability
-
-
-
-7
Reduction in the carrying amount of right-of-use assets
131
132
158
186
Stock-based compensation
263
342
289
236
Non-cash interest expense
129
130
127
124
Allowance for credit losses
41
-1
-25
13
Amortization of acquired intangible assets
-
-
-
4
Change in fair value of warrant liabilities
-44
219
-482
285
Gain on sale of asset held for sale
-
-
700
-
Realized/unrealized (gain)/ loss in investment, related party
-1
-
-1
1
Loss from termination of operating leases
-3
-1
-19
-
Accounts receivable
1,707
-3,413
4,272
-947
Other receivables, related party
55
-1
68
-68
Prepaid expenses and other assets
-77
-1,219
1,537
236
Other assets, related party
-427
-25
-47
-220
Inventories
-79
-307
872
301
Accounts payable
681
1,780
-1,784
-630
Accounts payable, related parties, net
-217
-3,497
2,825
1,316
Operating lease liabilities
-174
-10
-137
-175
Accrued expenses and other liabilities
-754
566
-1,660
746
Cash flows used in operating activities
-1,658
-70
-2,376
-3,823
Sales of investment, related party
-
-
0
0
Purchase of intangible assets
-
-
0
0
Proceeds from sale of asset held for sale
-
-
3,000
-
Purchases of property and equipment
0
5
-1
-1
Cash flows used in investing activities
0
-5
3,001
1
Proceeds from issuance of series b-1 preferred stock and warrants to purchase series b-3 preferred stock, net of issuance costs
-
-
0
0
Proceeds from issuance of series b-3 preferred stock from exercise of warrants
-
-
0
0
Payment to extinguish line of credit
-
-
-
0
Payment of principal short-term debt
-
-
0
0
Proceeds from issuance of series c preferred stock, net of offering costs
-
-
2,350
8,500
Cash flows provided by financing activities
-
-
2,350
0
Net increase in cash and cash equivalents
-
-
2,975
-
Net change in cash, cash equivalents
-1,658
-75
2,975
-3,822
Cash, cash equivalents and restricted cash, at the beginning of the period
6,517
6,592
3,617
6,105
Cash, cash equivalents and restricted cash, at the end of the period
4,859
6,517
6,592
3,617
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Net change in cash,
cash equivalents
-$1,658K
(-224.29%↓ Y/Y)
Accounts payable
$681K
(-71.77%↓ Y/Y)
Other assets, related
party
-$427K
(-144.81%↓ Y/Y)
Stock-based compensation
$263K
(-38.26%↓ Y/Y)
Reduction in the carrying
amount of right-of-use...
$131K
(-66.06%↓ Y/Y)
Non-cash interest
expense
$129K
(-46.25%↓ Y/Y)
Inventories
-$79K
(96.98%↑ Y/Y)
Prepaid expenses and
other assets
-$77K
(-71.11%↓ Y/Y)
Depreciation and
amortization
$65K
Allowance for credit
losses
$41K
(171.93%↑ Y/Y)
Loss from
termination of operating...
-$3K
Realized/unrealized (gain)/ loss in
investment, related party
-$1K
(-150.00%↓ Y/Y)
Cash flows used in
operating activities
-$1,658K
(76.85%↑ Y/Y)
Canceled cashflow
$1,897K
Accounts receivable
$1,707K
(220.38%↑ Y/Y)
Accrued expenses and
other liabilities
-$754K
(-149.48%↓ Y/Y)
Net loss
-$604K
(93.66%↑ Y/Y)
Accounts payable,
related parties, net
-$217K
(95.36%↑ Y/Y)
Operating lease
liabilities
-$174K
(53.10%↑ Y/Y)
Other receivables,
related party
$55K
Change in fair value of
warrant liabilities
-$44K
(93.73%↑ Y/Y)
Buy us a coffee